anti-angiogenic
Showing 1 - 25 of >10,000
Predict Efficacy of Anti-angiogenic Therapy in Ovarian Cancer
Active, not recruiting
- Epithelial Ovarian Cancer
- liquid biopsy
-
Aviano, ItalyCentro di Riferimento Oncologico (CRO), IRCCS
May 16, 2023
Brain Tumors by Advanced MRI
Completed
- Glioblastoma
- Avastin
- +5 more
-
Boston, MassachusettsMassachusetts general Hospital
Apr 6, 2022
Collateral Damage From COVID-19 Pandemic Observed in Patients
Completed
- Age Related Macular Degeneration
- +2 more
- Questionnaire
- Data collection up to 1 year
-
Ecully, France
- +3 more
Mar 2, 2022
Ocular Blood Flow in Colorectal Cancer Patients
Terminated
- Metastatic Colorectal Cancer
-
Vienna, AustriaMedical University of Vienna
Apr 23, 2022
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
Recruiting
- Hepatocellular Carcinoma
- Anti-angiogenic agents plus anti-PD-1/PD-L1 antibodies
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Jul 23, 2021
Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)
Active, not recruiting
- Metastatic Renal Cell Carcinoma
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 25, 2023
Hereditary Hemorrhagic Telangiectasia Trial in Toronto (Topical timolol maleate, saline drops)
Completed
- Hereditary Hemorrhagic Telangiectasia
- Topical timolol maleate
- placebo saline drops
-
Toronto, Ontario, CanadaSt. Michael's Hospital
Nov 19, 2021
Osteonecrosis Due to Drugs, Jaw Trial in Besançon (Human Amniotic Membrane, Conventional/Standard treatment)
Active, not recruiting
- Osteonecrosis Due to Drugs, Jaw
- Human Amniotic Membrane
- Conventional/Standard treatment
-
Besançon, FranceCHU de Besancon
Dec 21, 2022
18F-fluorodeoxyglucose Positron Emission Tomography and Brain
Recruiting
- Glioblastoma
- FDG PET
- +2 more
-
Nîmes, FranceCHU de Nimes
Oct 15, 2021
Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)
Recruiting
- Glioma
- +6 more
- Metronomic Cyclophosphamide
- Thalidomide
-
Saint Louis, MissouriWashington University School of Medicine
Sep 22, 2021
Colorectal Cancer Trial in Dijon (OCT- Angiographie)
Recruiting
- Colorectal Cancer
- OCT- Angiographie
-
Dijon, France
- +1 more
Jul 2, 2021
Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and
Completed
- Preeclampsia
- Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections
-
Indianapolis, IndianaRiley Hospital for Children
Feb 22, 2022
NSCLC Trial in Changsha (envafolimab)
Enrolling by invitation
- Non-small Cell Lung Cancer
-
Changsha, Hunan, Chinathe second Xiangya hospital
May 1, 2022
Screening of Preeclampsia and Intrauterine Growth Restriction
Completed
- Preeclampsia
- Intrauterine Growth Restriction
- Ultrasound study of the placenta
- Measurement of angiogenic and anti-angiogenic factors (sFlt-1 and PlGF) in the first trimestre blood test
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Mar 8, 2022
Rare Tumor, Refractory Tumor Trial in Shanghai (Gefitinib, Erlotinib, Afatinib)
Recruiting
- Rare Tumor
- Refractory Tumor
- Gefitinib
- +11 more
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Feb 16, 2022
Eyes With Diabetic Retinopathy
Recruiting
- Diabetic Retinopathy
-
Daegu, Kyungsangpookdo, Korea, Republic ofDong Ho Park
Feb 17, 2021
Therapeutic Combination in Advanced or Metastatic Kidney Cancer
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Blood collection
- Tumour samples
-
Paris, France
- +1 more
Mar 9, 2022
SNP-polymorphisms in Post-infarction Cardiac Remodeling
Completed
- Myocardial Infarction
- SNP polymorphisms of the promoter regions pro - and anti-inflammatory cytokines and angiogenic growth factor
-
Tomsk, Tomskii Region, Russian FederationCardiology Research Institute of Tomsk National Research Medical
Oct 5, 2021
Hepatocellular Carcinoma Trial in Shanghai (Anti-angiogenic Targeted Drugs, Ginsenoside Rg3, TACE)
Not yet recruiting
- Hepatocellular Carcinoma
- Anti-angiogenic Targeted Drugs
- +2 more
-
Shanghai, Shanghai, ChinaEastern hepatobilliary surgery hospital
Aug 19, 2020
Colorectal Cancer Trial in Hangzhou (Carilizumab + anti-angiogenic TKIs (available with fuquitinib, rigofenib, apatinib, etc.),
Unknown status
- Colorectal Cancer
- Carilizumab + anti-angiogenic TKIs (available with fuquitinib, rigofenib, apatinib, etc.)
- Carilizumab + anti-angiogenic TKIs (available with fuquitinib, rigofenib, apatinib, etc.)+Irinotecan
-
Hangzhou, Zhejiang, ChinaZhejiang Province Cancer Hospital
Jun 22, 2020
Anti-angiogenic Treatment in Recurrent Glioblastoma
Recruiting
- Adult Glioblastoma
- +2 more
- 3-Tesla conventional magnetic resonance imaging
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 6, 2020
Colon Cancer With Metastases to the Liver Trial in Argentina, United States (LC beads loaded with Irinotecan, Oxaliplatin,
Completed
- Colon Cancer With Metastases to the Liver
- LC beads loaded with Irinotecan
- +4 more
-
Huntsville, Alabama
- +9 more
Jun 9, 2021
Kidney Cancer Trial in Marseille (Blood and tumor samples)
Recruiting
- Kidney Cancer
- Blood and tumor samples
-
Marseille, FranceInstitut Paoli Calmettes
Jan 8, 2020